Heart medicine heartlessly costly for India’s poor

GOD0777INDCardiovascular medicines can be a major financial burden for millions of people living in India and other low- or middle-income countries, according to a new study.

The study, carried out in India by researchers from the University of Chicago and published May in PLOS ONE, found that buying cardiovascular medications could have the effect of increasing poverty figures by 2—3 per cent.

Kiran Raj Pandey, lead author of the study, tells SciDev.Net: “The most shocking finding was that 17 million rural and 10 million urban people would be impoverished just because they took drugs they needed. For cardiovascular medications alone to cause this amount of financial burden is a very significant.”

Read the full article in SciDev.net